Locations:
Search IconSearch

Tag: glioblastoma

Dr. Andrew Dhawan against a decorative background with podcast icon overlay
December 16, 2025/Neurosciences/Brain Tumor

Emerging Technologies in Brain Tumor Management (Podcast)

Advances in genomics, spinal fluid analysis, wearable-based patient monitoring and more

smartwatch being strapped to a woman's wrist
December 20, 2024/Neurosciences/Brain Tumor

Can Smartwatch Data Predict Progression and Detect Complications in Patients With Glioblastoma?

Researchers use AI tools to compare clinical events with continuous patient monitoring

Hydrogen sulfide

Can Boosting Hydrogen Sulfide Bolster Standard-of-Care Glioblastoma Therapy to Extend Survival?

Cleveland Clinic researchers pursue answers on basic science and clinical fronts

23-CNR-4210971-CQD-Hero-650×450 Dr Yu
October 9, 2023/Cancer/Radiation Oncology

Pathway Cross-Talk Suggests New Approach to Glioblastoma Treatment

New research from Cleveland Clinic helps explain why these tumors are so refractory to treatment, and suggests new therapeutic avenues

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

23-NEU-4229690-CQD-Podcast-Hero-650×450

Investigating Mitochondria Transfer in Glioblastoma (Podcast)

New research focuses on tumorigenic aspects of communication among brain cells

Astrocy

Mitochondria Transfer From Healthy Astrocytes Fuels Glioblastoma Tumorigenicity

Study demonstrates its role in tumor lethality, raises prospect of therapeutic targets

22-NEU-3409069-CQD-Hero-650×450
December 20, 2022/Cancer

Survival Is Associated With Subsets of T Cells in Recurrent Glioblastoma Treated With SL-701

Can T-cell immunophenotyping help inform treatment decisions?

22-NEU-3367462-T-cells-650×450
December 6, 2022/Cancer

Phase 1 Trial Shows Drug-Resistant Immunotherapy for Glioblastoma Is Safe and Feasible

Intracranial injection of supercharged immune cells proceeds to phase 2 testing

Glioblastoma

Failed Alzheimer’s Drug Shows Promise for Treating Glioblastoma in Preclinical Study

BACE1 inhibitor reduces cancer progression in models of glioblastoma

21-NEU-2498412-brain-tumor-imaging-studies-650×450

High-Fat Diet Linked to Aggressive Glioblastoma in Preclinical Study

Findings implicate hydrogen sulfide dysfunction, point to potential treatment strategies

BackPage 1 of 4Next

Advertisement

Ad